75440830
Feb 26, 1998
RAPIGENE INC.
Subscribe
Genetic material, namely, single nucleotide polymorphisms or DNA fragments for clinical, diagnostic and therapeutic use for the treatment of cancer, autoimmune diseases, infectious diseases, inflammatory diseases and genetic diseases